cstnprapp12.centerstone.lan

Ketamine/Esketamine Program for Treatment-Resistant Depression

Centerstone has begun a new therapy program for individuals seeking treatment for severe depression at our Florida location.

About the Program

We are now certified to offer Spravato, a nasal spray that contains the FDA-approved medication Esketamine, and ketamine infusion therapy for people who have been treated for depression with no improvement in symptoms.

Both Spravato and ketamine infusion therapy are administered under the supervision of a medical professional, and patients are required to complete a comprehensive screening with a Centerstone physician prior to receiving treatment. Ketamine infusion therapy lasts approximately four hours for each dosage; Esketamine treatment takes approximately two hours.

Screenings and treatments are scheduled at our Bradenton, Fla., locations.

Patient Support

The Johnson & Johnson Patient Assistance Foundation Inc. (JJPAF) is an independent, nonprofit organization committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. For more information, visit jjpaf.org.

Once Spravato has been prescribed, Janssen CarePath can help you find the resources you may need to help get started on the medication and stay on track. For more information, visit janssencarepath.com.

Frequently Asked Questions

What are Ketamine and Esketamine?

  • Ketamine is a medication traditionally used for anesthesia during surgery that was approved for use in the United States in 1970. While it does have a history as a drug of abuse, it is a safe and valuable medication when properly administered by a trained medical professional.
  • Esketamine was introduced as an anesthetic in Germany in 1997 and was then marketed in other countries. It is part of ketamine but differs slightly on a molecular level.

How long have they been used to treat depression?

  • For the past decade or so, researchers began studying the use of ketamine as an application for Treatment-Resistant Depression (TRD). Studies indicated that ketamine was highly successful at reducing symptoms of depression; some indicated relief of symptoms in about 80% of people prescribed. Despite their molecular differences, ketamine and Esketamine act essentially the same in their uses and effectiveness for treating TRD. Esketamine was approved by the U.S. Food and Drug Administration (FDA) in March 2019 under the drug name SpravatoTM.

When should Esketamine be considered for use?

  • Esketamine is approved to treat Treatment-Resistant Depression, which is diagnosed in patients who have suffered at least one major depressive episode and have experienced at least two failed drug therapies.

How is Esketamine used in treatment?

  • Spravato (Esketamine) is a fast-acting nasal spray approved for use in conjunction with an oral antidepressant in adults with Treatment-Resistant Depression.

How long does the treatment take?

  • For Esketamine administration, patients will need
    • 2 treatments per week for the first month (8 total)
    • 1 treatment per week for the second month (4 total)
    • 1 treatment every two weeks for the third month (2 total)
  • The initial visit will take about 2 hours; each subsequent appointment will take about 3 hours each.

Does insurance cover treatment costs?

  • Your insurance provider may cover Esketamine or Spravato. By enrolling in Janssen CarePath, you can receive guidance on submitting claims so that Spravato can be considered under your pharmacy benefits.

Do I need a referral before seeking treatment?

  • If you think Esketamine may be a good fit for you, it is a good idea to talk with your health care provider, but a referral by a medical professional is not required.

When can I expect to see results?

  • Patients typically begin to feel the effects within a few hours of treatment to the day after treatment. If the treatment schedule is adhered to, most patients will continue to feel the effects for up to several months.

For More Information

To learn more about the Spravato nasal spray, including answers to frequently asked questions, go online to spravato.com.

In the News

To see a report from WFLA-TV about this program, click here.

Call Today

For more information about Spravato self-pay rates, ketamine infusion therapy and Centerstone’s depression care services or to make an appointment, call (941) 782-4610.


Related Posts

Gambling

Centerstone to host Problem Gambling Awareness Month events in Illinois

Centerstone is collaborating with the National Council on Problem Gambling and the Illinois Council on Problem Gambling to dedicate March to helping people “have the conversation” about problem gambling. “Not only will we be spotlighting Centerstone’s gambling disorder services, but we will also strive to increase public awareness of problem gambling, reduce stigma, and let ...

Free counseling is available for the metro St. Louis military community

Military life is challenging, due to deployments and temporary duty assignments that take service members away from home and numerous relocations. These challenges impact not only service members but also their spouses and children, and many of these effects can last after leaving the military. “At Centerstone, our providers are specifically trained in military culture, ...

Military Services

Centerstone’s Jodie Robison Joins American Counseling Association’s 2019-2020 Research and Knowledge Committee

Dr. Jodie Robison, Executive Director of Centerstone’s Military Services, has been selected to the 2019-2020 Research and Knowledge Committee of the American Counseling Association (ACA). Robison first joined Centerstone in 2007 as a behavioral health worker in Pediatric Integrated Care before establishing her own private behavioral health practice in 2012. Before she became executive director ...

Kentucky

Centerstone To Receive 2018 Kentucky Nonprofit Award

Kentucky Nonprofit Network will recognize Centerstone at the 16th annual Kentucky Nonprofit Leadership Forum October 18 in Lexington. Centerstone will receive the 2018 Innovative Nonprofit Award, which recognizes an organization that implements inventive, nontraditional programs or methods that effectively meet community needs. The award recipient is required to demonstrate creativity and vision in finding unique ...

No image set - Centerstone logo
Depression

Centerstone’s Ketamine/Esketamine Program for Treatment-Resistant Depression featured on news broadcast

Centerstone’s new therapy program for individuals seeking treatment for severe depression was featured recently on WFLA-TV. Through the program, Centerstone can offer Spravato, a nasal spray that contains the FDA-approved medication Esketamine, and ketamine infusion therapy for people who have been treated for depression with no improvement in symptoms. To learn more about this program, ...

No image set - Centerstone logo
Indiana

Centerstone’s POPS Program Coaches Fathers

The Providing Opportunities for Parental Success (POPS) program is a five year federally funded grant project housed at Centerstone Indiana. POPS focuses on developing and sustaining responsible fatherhood. Eligible fathers (including biological, step, adoptive and expectant fathers) can receive services in Bartholomew, Brown, Lawrence, Monroe, Morgan and Owen counties. The project hopes to specifically reach ...

No image set - Centerstone logo
Family Matters

Centerstone Awarded $2 Million from Administration for Children and Families

Centerstone was awarded a $1.9 million grant from the U.S. Department of Health and Human Services Children’s Bureau, an office of the Administration for Children and Families, to increase well-being, improve permanency, and enhance the safety of children who are in an out-of-home placement or are at risk of being place in an out-of-home case as a result of a parent’s or caretaker’s substance use. ...

Indiana

Centerstone Receives Grants to Support Indiana Youth

Centerstone was recently awarded two grants to fund treatment for Indiana youth. These grants from the PNC Foundation and the Community Foundation of Southern Indiana and will help expand services in Bartholomew, Jackson, Jennings, and Clark counties. The PNC Foundation provided $5,000 in support of Say It Straight, an evidence-based prevention program designed to increase empowering communication skills and ...

No image set - Centerstone logo
Kentucky

Belle Holloway, Senior Support Broker

My name is Belle Holloway and I work at Developmental Services as a Senior Support Broker (fancy name for case manager) and oversee intakes for the (MPW) Michelle P. Waiver. The MPW is a wonderful program that began in Kentucky in 2008 to provide services for individuals with intellectual and/or developmental disabilities through their life ...

Indiana

Members of Administration Visit Centerstone-partnered Program

Recently, Kellyanne Conway, U.S. Surgeon General Jerome Adams, Second Lady Karen Pence, and U.S. Department of Labor Secretary Alexander Acosta visited Belden Inc. in Richmond IN to learn about the “Pathways to Employment” program in which Centerstone partners with Belden. The program offers applicants that fail pre-employment drug screens an option for tailored rehabilitation, and the chance ...